Showing all 16 results
Alfuzosin & Dutasteride Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Bi-Layer or Capsule-in-Tablet format, packed in high-barrier Alu-Alu blister strips to ensure the stability of the moisture-sensitive Dutasteride.
Active Ingredient Strength Primary Clinical Function Alfuzosin HCl (Extended-Release) USP/BP 10 mg The Rapid Reliever: Provides immediate improvement in urine flow by relaxing prostate muscles. Dutasteride USP/BP 0.5 mg The Long-Term Shaper: Reduces the physical size of the prostate to prevent the need for surgery. Excipients Hydrophilic Matrix Controlled-Release System: Engineered to provide synchronized 24-hour therapeutic coverage with once-daily dosing. Alfuzosin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Extended-Release (ER) Tablet, packed in high-barrier Alu-Alu blister strips to ensure API stability.
Active Ingredient Strength Primary Clinical Function Alfuzosin Hydrochloride USP/BP 10 mg The Standard Therapeutic Anchor: The globally validated once-daily dose for moderate-to-severe BPH symptoms. Excipients Extended-Release Matrix Controlled-Delivery System: Engineered to provide synchronized 24-hour therapeutic coverage, eliminating the need for multiple daily doses. Bethanecol Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Bioavailability Tablet, packed in secure Alu-PVC or Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Bethanechol Chloride USP/BP 10 mg The Pediatric & Titration Unit: Ideal for initial dosing or mild cases of gastric atony. Bethanechol Chloride USP/BP 25 mg The Urology Anchor: The standardized therapeutic dose for managing post-operative urinary retention. Excipients Proprietary Matrix Acid-Stable Formulation: Engineered to survive the gastric environment for consistent intestinal absorption. Finasteride Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hazard-Shielded Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the highly potent active pharmaceutical ingredient.
Active Ingredient Strength Primary Clinical Function Finasteride USP/Ph.Eur. 1 mg The Global Dermatology Standard: The definitive micro-dose engineered specifically for the lifelong, daily maintenance of Androgenetic Alopecia (Male Pattern Hair Loss). Finasteride USP/Ph.Eur. 5 mg The Global Urology Standard: High-efficacy macro-dose utilized for the aggressive shrinkage of the prostate gland in symptomatic Benign Prostatic Hyperplasia (BPH). Excipients Lactose Monohydrate / Microcrystalline Cellulose / Sodium Starch Glycolate / Docusate Sodium / Magnesium Stearate / Premium Polymeric Film Diluent / Binder / Superdisintegrant / Surfactant / Heavy Opadry Film-Coating (Engineered specifically to form an impenetrable physical barrier over the tablet core. This completely seals the teratogenic API, ensuring absolute safety for female pharmacists and caregivers handling the medication) *Pack Sizes: 10×10 Blisters or Bottles of 30/100 (Optimized specifically for strict, lifelong chronic urology and dermatology dispensing regimens).
Flavoxate HCL Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Macrodose Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the active hydrochloride salt.
Active Ingredient Strength Primary Clinical Function Flavoxate Hydrochloride USP/Ph.Eur. 200 mg The Global Urological Standard: The definitive macrodose therapeutic unit utilized for rapid, acute suppression of agonizing bladder spasms and chronic overactive bladder maintenance. Excipients Microcrystalline Cellulose / Sodium Starch Glycolate / Povidone / Magnesium Stearate / Premium Polymeric Film Diluent / Superdisintegrant / Binder / Lubricant / Heavy Film-Coating (Engineered specifically utilizing advanced “Rapid-Burst” superdisintegrants to ensure the massive 200mg tablet shatters instantly upon contact with gastric fluid, guaranteeing hyper-fast pain relief while masking the bitter taste) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict 3-to-4 times daily acute dispensing regimens).
Flutamide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the antiandrogen API.
Active Ingredient Strength Primary Clinical Function Flutamide USP/Ph.Eur. 250 mg Global Uro-Oncology Standard: The definitive therapeutic unit utilized for chronic, 8-hourly maintenance in Maximum Androgen Blockade (MAB) protocols. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Sodium Starch Glycolate / Sodium Lauryl Sulfate / Magnesium Stearate / Premium Polymeric Film Diluent / Binder / Superdisintegrant / Surfactant / Heavy Film-Coating (Engineered specifically to lock the potent antiandrogen API safely inside the tablet, completely preventing handler and pharmacist exposure to the hazardous hormonal dust) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for strict, high-volume chronic oncology dispensing regimens).
Mirabegron Extended-Release Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hydrophilic Matrix ER Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute physical stability of the extended-release polymers.
Active Ingredient Strength Primary Clinical Function Mirabegron Ph.Eur./USP 25 mg (ER) Initiation / Renal Standard: Base therapeutic unit for assessing patient tolerance and for use in patients with severe renal or hepatic impairment. Mirabegron Ph.Eur./USP 50 mg (ER) Global Urology Standard: High-efficacy adult maintenance therapy for maximum suppression of urge urinary incontinence and detrusor overactivity. Excipients Polyethylene Oxide / Hypromellose (HPMC) / Butylated Hydroxytoluene (BHT) / Magnesium Stearate / Premium Opadry Film Swellable ER Polymer / Hydrophilic Matrix Base / Antioxidant / Lubricant (Engineered specifically to form an impenetrable, slow-eroding gel matrix in the GI tract, strictly metering the release of the active ingredient over 24 hours) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic urology dispensing regimens).
Nitrofurantoin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Dual-Release Capsule or Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the nitrofuran compounds.
Active Ingredient Strength Primary Clinical Function Nitrofurantoin (Macrocrystals) USP/Ph.Eur. 50 mg Prophylactic / Pediatric Standard: Base therapeutic unit for long-term prevention of recurrent UTIs and pediatric dosing. Nitrofurantoin (Macrocrystals 25mg + Monohydrate 75mg) USP 100 mg Global Acute UTI Standard: Premium dual-release adult maintenance dose for the rapid eradication of acute uncomplicated cystitis. Excipients Carbomer 934P / Povidone K30 / Sugar Spheres / Talc / Magnesium Stearate / Titanium Dioxide Hydrophilic Polymer Matrix / Binder / Core Substrate / Glidant (Engineered specifically to form a viscous gel upon swallowing, pacing the gastric release perfectly to prevent nausea while ensuring maximum urinary concentration) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for strict 5-to-7 day acute urology dispensing regimens).
Oxybutynin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Polymeric Matrix Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE desiccant bottles to ensure the absolute chemical stability of the controlled-release hydrogel network.
Active Ingredient Strength Primary Clinical Function Oxybutynin Chloride USP/Ph.Eur. 5 mg (ER) Initiation Standard: Base once-daily titration unit for the gradual introduction of antimuscarinic therapy. Oxybutynin Chloride USP/Ph.Eur. 10 mg / 15 mg (ER) Global Clinical Standard: Advanced maintenance doses for severe, refractory Overactive Bladder and neurogenic detrusor overactivity. Excipients Hypromellose (HPMC) / Lactose Anhydrous / Macrogol (PEG) / Magnesium Stearate / Titanium Dioxide Hydrophilic Polymer Matrix / Diluent / Plasticizer / Premium Film-Coating (Engineered specifically to form a highly viscous external gel barrier upon swallowing, controlling the exact 24-hour drug diffusion rate) *Pack Sizes: Bottles of 30 or 10×10 Alu-Alu Blisters (Optimized specifically for strict, high-compliance 30-day chronic urology dispensing regimens).
Phenazopyridine Hydrochloride Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant high-density PVC/PVDC or Alu-PVC blister strips to ensure absolute chemical stability and prevent dye leakage.
Active Ingredient Strength Primary Clinical Function Phenazopyridine HCl USP/Ph.Eur. 100 mg OTC Standard: Base therapeutic unit for mild to moderate UTI symptom relief. Phenazopyridine HCl USP/Ph.Eur. 200 mg Prescription Standard: Maximum adult dose for severe, acute dysuria and post-surgical trauma. Excipients Microcrystalline Cellulose / Sodium Starch Glycolate / Povidone / Magnesium Stearate / Heavy Carnauba Wax Coating Diluent / Superdisintegrant / Binder / Lubricant / Premium Film-Coating (Engineered specifically to seal the intense red dye inside the tablet, preventing it from staining the patient’s hands or mouth upon swallowing) *Pack Sizes: 10×10 Blisters (Optimized specifically for high-turnover acute dispensing and short-term 2-day urology protocols).
Phenazopyridine tablets
FreeA Phenazopyridine tablet is a urinary tract analgesic used for the short-term relief of symptoms like pain, burning, and urgency caused by urinary tract infections (UTIs), surgery, or injury.
SILODOSIN 8 MG TABLET
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the active pharmaceutical ingredient.
Active Ingredient Strength Primary Clinical Function Silodosin INN/Ph.Eur. 8 mg Global Clinical Standard: Maximum adult daily dose for the rapid relief of lower urinary tract symptoms (LUTS) associated with BPH. Excipients Mannitol / Pregelatinized Starch / Sodium Stearyl Fumarate / Hypromellose / Titanium Dioxide Diluent / Binder / Lubricant / Film-Coating (Engineered for highly synchronized gastric dissolution and optimal bioavailability) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for high-compliance 30-day urology dispensing regimens).
Solifenacin Succinate Tablets
FreeA Solifenacin Succinate tablet is an antimuscarinic (anticholinergic) medication used to treat symptoms of an overactive bladder, such as frequent or urgent urination and urinary incontinence.
Tamsulosin 0.4 Mg + Dutasteride 0.5 Mg Tablets
FreeA tablet or capsule containing Tamsulosin 0.4 mg + Dutasteride 0.5 mg is a dual-action combination medication used to treat moderate to severe symptoms of Benign Prostatic Hyperplasia (BPH), or an enlarged prostate.
Tamsulosin 0.4 mg tablet
FreeA Tamsulosin 0.4 mg tablet (or capsule) is a selective alpha-1 adrenergic receptor antagonist used to treat symptoms of an enlarged prostate, also known as Benign Prostatic Hyperplasia (BPH).
Tamsulosin 0.4Mg + Finasteride 5Mg Tablet
FreeA Tamsulosin 0.4mg + Finasteride 5mg tablet is a combination medication used to manage Benign Prostatic Hyperplasia (BPH), also known as an enlarged prostate. This dual therapy is designed to provide both rapid symptom relief and long-term reduction of prostate size.
